Voltar
Artigo Revisado por pares
BIBTEX RIS

Safety and immunogenicity of a modified-vaccinia-virus-Ankara-based influenza A H5N1 vaccine: a randomised, double-blind phase 1/2a clinical trial

2014; Elsevier BV; Volume: 14; Issue: 12 Linguagem: Inglês

10.1016/s1473-3099(14)70963-6

ISSN

1474-4457

Autores

Joost H. C. M. Kreijtz, Marco Goeijenbier, Fleur M. Moesker, L. Van den Dries, Simone Goeijenbier, Heidi L.M. De Gruyter, Michael H. Lehmann, Gerrie de Mutsert, David van de Vijver, Asisa Volz, Ron A. M. Fouchier, Eric C. M. Van Gorp, Guus F. Rimmelzwaan, Gerd Sutter, Albert D. M. E. Osterhaus,

Tópico(s)

Bacillus and Francisella bacterial research

Referência(s)